Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR)

被引：0
|
作者：
Mélanie Dos Santos
Justine Lequesne
Alexandra Leconte
Stéphane Corbinais
Aurélie Parzy
Jean-Marc Guilloit
Sharmini Varatharajah
Pierre-Emmanuel Brachet
Marine Dorbeau
Dominique Vaur
Louis-Bastien Weiswald
Laurent Poulain
Corentin Le Gallic
Marie Castera-Tellier
Marie-Pierre Galais
Bénédicte Clarisse
机构：
[1] UNICANCER,Clinical Research Department
[2] Centre François Baclesse,Department of Medical Oncology
[3] UNICANCER,Department of Surgery
[4] Centre François Baclesse,Department of Pathology
[5] UNICANCERCentre François Baclesse,Department of Cancer Biology and Genetics
[6] UNICANCERCentre François Baclesse,undefined
[7] UNICANCERCentre François Baclesse,undefined
[8] UNICANCER,undefined
[9] Centre François Baclesse,undefined
[10] Normandie University,undefined
[11] UNICAEN,undefined
[12] ANTICIPE,undefined
[13] ORGAPRED Platform,undefined
来源：
BMC Cancer | / 22卷
关键词：
Gastric cancer; Gastroesophageal junction cancer; Neoadjuvant treatment; Immunotherapy; Spartalizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma
    Luigi Di Lauro
    Laura Giacinti
    Maria Grazia Arena
    Domenico Sergi
    Silvia Ileana Fattoruso
    Diana Giannarelli
    Massimo Lopez
    Journal of Experimental & Clinical Cancer Research, 28
  • [22] Paclitaxel, oxaliplatin, 5-fluorouracil and leucovorin combination chemotherapy in patients with recurrent or metastatic gastric cancer
    Lan, Yan-qin
    Wu, Ri-ping
    Huang, Xiao-bing
    Wang, Xin-li
    Zhong, Dong-ta
    Huang, Chuan-yong
    Song, Jin-tian
    TUMORI JOURNAL, 2018, 104 (01): : 22 - 29
  • [23] Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO
    Thorsten O. Götze
    Pompiliu Piso
    Sylvie Lorenzen
    Ulli S. Bankstahl
    Claudia Pauligk
    Moustafa Elshafei
    Giuseppe Amato
    Daniel Reim
    Wolf O. Bechstein
    Alfred Königsrainer
    Stefan P. Mönig
    Beate Rau
    Matthias Schwarzbach
    Salah-Eddin Al-Batran
    BMC Cancer, 21
  • [24] Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"-(FLOT9) trial of the AIO/CAOGI /ACO
    Goetze, Thorsten O.
    Piso, Pompiliu
    Lorenzen, Sylvie
    Bankstahl, Ulli S.
    Pauligk, Claudia
    Elshafei, Moustafa
    Amato, Giuseppe
    Reim, Daniel
    Bechstein, Wolf O.
    Koenigsrainer, Alfred
    Moenig, Stefan P.
    Rau, Beate
    Schwarzbach, Matthias
    Al-Batran, Salah-Eddin
    BMC CANCER, 2021, 21 (01)
  • [25] PHASE-II STUDY OF THE ETOPOSIDE, LEUCOVORIN AND FLUOROURACIL COMBINATION FOR PATIENTS WITH ADVANCED GASTRIC-CANCER UNSUITABLE FOR AGGRESSIVE CHEMOTHERAPY
    DIBARTOLOMEO, M
    BAJETTA, E
    DEBRAUD, F
    BOCHICCHIO, AM
    GEBBIA, V
    BOZZETTI, F
    DOCI, R
    BONFANTI, G
    COZZAGLIO, L
    ONCOLOGY, 1995, 52 (01) : 41 - 44
  • [26] A phase II study of 5-fluorouracil, leucovorin and cisplatin (FLP) for metastatic gastric cancer
    Ychou, M
    Astre, C
    Rouanet, P
    Fabre, JM
    SaintAubert, B
    Domergue, J
    Ribard, D
    Ciurana, AJ
    Janbon, C
    Pujol, H
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (11) : 1933 - 1937
  • [27] Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer
    Park, Keon Woo
    Ahn, Jin Seok
    Park, Young Suk
    Lee, Jeeyun
    Kang, Jung Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Im, Young-Hyuck
    Kang, Won Ki
    Park, Keunchil
    Lee, Soon Il
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (01) : 17 - 21
  • [28] Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer
    Keon Woo Park
    Jin Seok Ahn
    Young Suk Park
    Jeeyun Lee
    Jung Hoon Kang
    Joon Oh Park
    Ho Yeong Lim
    Young-Hyuck Im
    Won Ki Kang
    Keunchil Park
    Soon Il Lee
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 17 - 21
  • [29] Combination of docetaxel and irinotecan as a second-line treatment of metastatic gastric cancer: a phase II study
    Abdelaziz, Reham
    Hegazy, Amira
    Sohaib, Ahmed
    ONCOLOGY IN CLINICAL PRACTICE, 2025,
  • [30] Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer
    Lorenzen, S.
    Pauligk, C.
    Homann, N.
    Schmalenberg, H.
    Jaeger, E.
    Al-Batran, S-E
    BRITISH JOURNAL OF CANCER, 2013, 108 (03) : 519 - 526
12345